Basilea Pharmaceutica, Ltd. (Basilea)

Oncology Corporate Profile

HQ Location

Grenzacherstrasse 487
PO Box 400 , Basel, Switzerland

Company Description

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). Through the fully integrated research and development operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and non-response to current treatment options.

Website: http://www.basilea.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BAL101553microtubule inhibitorVarious cancer typesI

View additional information on product candidates here »

Source


http://www.basilea.com

Recent News Headlines

There are no news items to display